| A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer S Postel-Vinay, I Bajrami, L Friboulet, R Elliott, Y Fontebasso, N Dorvault, ... Oncogene 32 (47), 5377-5387, 2013 | 97 | 2013 |
| Drug development for metastasis prevention Y Fontebasso, SM Dubinett Critical Reviews™ in Oncogenesis 20 (5-6), 2015 | 63 | 2015 |
| The conserved Fanconi anemia nuclease Fan1 and the SUMO E3 ligase Pli1 act in two novel Pso2-independent pathways of DNA interstrand crosslink repair in yeast Y Fontebasso, TJ Etheridge, AW Oliver, JM Murray, AM Carr DNA repair 12 (12), 1011-1023, 2013 | 25 | 2013 |
| Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells SJ Pettitt, DB Krastev, HN Pemberton, Y Fontebasso, J Frankum, ... Scientific data 4 (1), 1-8, 2017 | 13 | 2017 |
| Identification of a human airway epithelial cell subpopulation with altered biophysical, molecular, and metastatic properties PC Pagano, LM Tran, N Bendris, S O'Byrne, HT Tse, S Sharma, ... Cancer Prevention Research 10 (9), 514-524, 2017 | 11 | 2017 |
| Regulation and role of actin dynamics in promoting premalignant cell migration MK Paul, A Basu, B Bisht, P Pagano, Y Fontebasso, K Krysan, L Tran, ... Cancer Research 79 (13_Supplement), 1030-1030, 2019 | 2 | 2019 |
| Corrigendum to “The conserved Fanconi anemia nuclease Fan1 and the SUMO E3 ligase Pli1 act in two novel Pso2-independent pathways of DNA interstrand crosslink repair in yeast … Y Fontebasso, TJ Etheridge, AW Oliver, JM Murray, AM Carr DNA repair 24, 150, 2014 | | 2014 |
| Genome-wide drug sensitivity screens in haploid mouse embryonic stem cells. SJ Pettitt, D Krastev, H Pemberton, Y Fontebasso, I Bajrami, I Kozarewa, ... European Journal of Cancer 50, 33-33, 2014 | | 2014 |
| An integrated approach for identifying E-cadherin synthetic lethality networks I Bajrami, SJ Pettitt, R Brough, H Pemberton, D Kastrev, Y Fontebasso, ... European Journal of Cancer 50, 50-50, 2014 | | 2014 |
| Cancer cells deficient in DNA mismatch repair (MMR) are selectively sensitive to inhibition of the DNA dependent protein kinase (DNA-PK) M Hewish, Y Fontebasso, SA Martin, R Elliott, KL Perks, A Konde, ... Cancer Research 74 (19_Supplement), 2931-2931, 2014 | | 2014 |
| Exacerbation of oxidative DNA damage as a synthetic lethal approach in mismatch repair deficient tumors Y Fontebasso, M Hewish, CJ Lord, A Ashworth Cancer Research 74 (19_Supplement), 2426-2426, 2014 | | 2014 |
| Abstract A09: Induced aggravation of oxidative DNA damage as a targeted synthetic lethal approach in mismatch repair-deficient tumors Y Fontebasso, CJ Lord, A Ashworth Molecular Cancer Therapeutics 12 (5_Supplement), A09-A09, 2013 | | 2013 |
| High-throughput screens identify PARP inhibition as being synthetically lethal with ERCC1 deficiency in non-small cell lung cancer cell lines. SC Postel-Vinay, I Bajrami, L Friboulet, M Aarts, Y Fontebasso, F Andre, ... Cancer Research 73 (8_Supplement), 617-617, 2013 | | 2013 |
| 288 Synthetic Lethality in ERCC1-deficient Non-Small Cell Lung Cancer S Postel-Vinay, I Bajrami, L Friboulet, I Jaco, Y Fontebasso, KA Olaussen, ... European Journal of Cancer, 88, 2012 | | 2012 |
| Novel insights into the DNA interstrand cross-link repair in Schizosaccharomyces pombe: characterisation of Fan1 through standard and high-throughput genetic analysis Y Fontebasso University of Sussex, 2011 | | 2011 |
| Data Descriptor: Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells SJ Pettitt, DB Krastev, HN Pemberton, Y Fontebasso, J Frankum, ... | | |
